Peripheral blood progenitor cell cycle kinetics following priming with pIXY321 in patients treated with the "ICE" regimen.

PURPOSE: Treatment with hematopoietic growth factors increases the percentage of hematopoietic progenitor cells in cell cycle. Following withdrawal of certain growth factors, preclinical data suggest that there is a transient fall in the percentage of progenitor cells in cycle below the baseline, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Murren, J. R., Gollerkeri, A., Anderson, S., Lutzker, S., Del Prete, S., Zelterman, D., Garrison, L., Smith, B.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578930/
https://www.ncbi.nlm.nih.gov/pubmed/10527363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2578930/
https://www.ncbi.nlm.nih.gov/pubmed/10527363

Ejemplares similares